<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">18952</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2018-22-2-148-158</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CARDIOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КАРДИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">TYPE 2 MYOCARDIAL INFARCTION: CLINICAL AND DEMOGRAPHIC FEATURES, LABORATORY AND INSTRUMENTAL ASSOCIATIONS</article-title><trans-title-group xml:lang="ru"><trans-title>КЛИНИКО-ДЕМОГРАФИЧЕСКИЕ ХАРАКТЕРИСТИКИ, РАСПРОСТРАНЕННОСТЬ ФАКТОРОВ РИСКА И СОПУТСТВУЮЩИХ ЗАБОЛЕВАНИЙ У ПАЦИЕНТОВ С ИНФАРКТОМ МИОКАРДА 2-ГО ТИПА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Hoang</surname><given-names>H T</given-names></name><name xml:lang="ru"><surname>Хоанг</surname><given-names>Х Ч</given-names></name></name-alternatives><email>lazarev@pfur.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kitbalyan</surname><given-names>A A</given-names></name><name xml:lang="ru"><surname>Китбалян</surname><given-names>А А</given-names></name></name-alternatives><email>lazarev@pfur.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lazarev</surname><given-names>P V</given-names></name><name xml:lang="ru"><surname>Лазарев</surname><given-names>П В</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, assistant of Department of internal diseases, Medical Institute Peoples’ Friendship University of Russia</p></bio><bio xml:lang="ru"><p>к.м.н., ассистент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики медицинского института</p></bio><email>lazarev@pfur.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Maiskov</surname><given-names>V V</given-names></name><name xml:lang="ru"><surname>Майсков</surname><given-names>В В</given-names></name></name-alternatives><email>lazarev@pfur.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shkolinikova</surname><given-names>E E</given-names></name><name xml:lang="ru"><surname>Школьникова</surname><given-names>Е Э</given-names></name></name-alternatives><email>lazarev@pfur.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Meray</surname><given-names>I A</given-names></name><name xml:lang="ru"><surname>Мерай</surname><given-names>И А</given-names></name></name-alternatives><email>lazarev@pfur.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Peoples’ Friendship University of Russia (RUDN University)</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет имени М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Vinogradov Clinical Hospital No. 64</institution></aff><aff><institution xml:lang="ru">ГБУЗ ГКБ имени В.В. Виноградова ДЗМ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>22</volume><issue>2</issue><issue-title xml:lang="en">VOL 22, NO2 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 22, №2 (2018)</issue-title><fpage>148</fpage><lpage>158</lpage><history><date date-type="received" iso-8601-date="2018-07-26"><day>26</day><month>07</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Hoang H.T., Kitbalyan A.A., Lazarev P.V., Maiskov V.V., Shkolinikova E.E., Meray I.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Хоанг Х.Ч., Китбалян А.А., Лазарев П.В., Майсков В.В., Школьникова Е.Э., Мерай И.А.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Hoang H.T., Kitbalyan A.A., Lazarev P.V., Maiskov V.V., Shkolinikova E.E., Meray I.A.</copyright-holder><copyright-holder xml:lang="ru">Хоанг Х.Ч., Китбалян А.А., Лазарев П.В., Майсков В.В., Школьникова Е.Э., Мерай И.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/18952">https://journals.rudn.ru/medicine/article/view/18952</self-uri><abstract xml:lang="en"><p>Background: Type 2 (T2) myocardial infarction (MI) is diagnosed in patients with acute coronary syndrome with increasing frequency. However, the information on etiology, pathogenetic mechanisms, instrumental and laboratory features is inconsistent. Purpose: to examine the clinical and demographic parameters, and results of routinely performed laboratory and instrumental test in patients with T2 MI and compare them with population characteristics of type 1 (T1) MI. Methods: We retrospectively included 450 consecutive patients admitted with acute MI diagnosed in accordance with the Third Universal Definition (2012) that underwent coronary angiography. T1 MI was diagnosed in the presence of intraluminal thrombus in the epicardial vessel, or absence of atherosclerotic plaque integrity with decreased myocardial blood flow (TIMI &lt; 3). All other patients were classified as having T2 MI. We analyzed electronic medical records to obtain their data. Student’s t-test and chi-square methods were used to compare single variables in patients with T1 and T2 MI. Multiple logistic regression was then performed to establish independent association of studied parameters with the type of MI. Results: Type 2 MI was diagnosed in 175 (39%) patients and was associated with increasing age (p = 0.007) and female gender (p = 0.01). T2 MI patients more frequently present without ST segment elevation (p = 0.001) and have lower troponin values (p = 0.001). They also had more often had a previous MI (p &lt; 0.001) and had undergone myocardial revascularisation (p = 0.002). The absence of obstructive coronary atherosclerosis was diagnosed in a small fraction of patients with T2 MI [12 (6.9%)]. Independent predictors of having T2 MI were the presence of anemia (p &lt; 0.001), left bundle branch block (p = 0.019), the absence of ST-segment elevation (p = 0.001), age ≥ 70 years (p = 0.014) and the absence of local wall motion abnormalilties on echocardiography (p = 0.002). Conclusion: Type 2 myocardial infarction is diagnosed in a substantial proportion of MI patients and is independently associated with concomitant anemia, left bundle branch block, absence of ST-segment elevation, older age, and the echocardiographic absence of local hypo- and akinesia of the left ventricle.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность: инфаркт миокарда 2-го типа (ИМ2Т) все чаще диагностируется у пациентов с острым коронарным синдромом. Однако литературные данные в отношении клинических особенностей данного заболевания противоречивы. Цель исследования: изучить клинико-демографические характеристики, результаты лабораторно-инструментальных исследований у больных с инфарктом миокарда 2-го типа (ИМ2Т) в сравнении с пациентами с инфарктом миокарда 1-го типа (ИМ1Т). Материал и методы: ретроспективно включено 450 последовательных пациентов, госпитализированных с ИМ, которым была выполнена коронарная ангиография. ИМ1Т диагностировался при наличии внутрисосудистого тромба в коронарной артерии или нарушении целостности атеросклеротической бляшки в сочетании со снижением кровотока (TIMI &lt; 3). Все остальные случаи были классифицированы как ИМ2Т. Для сравнения отдельных признаков у пациентов ИМ1Т и ИМ2Т обычно использовали критерий хи-квадрат (χ2) и t-критерий Стьюдента. Для выявления взаимосвязи отдельных параметров с типом ИМ использовались процедуры однофакторного и многофакторного логистического регрессионного анализа. Результаты: ИМ2Т был диагностирован у 175 (38,9%) пациентов с преобладанием среди них лиц старшего возраста (р = 0,007) и женского пола (р = 0,01). При ИМ2Т реже регистрировался подъем сегмента ST (р = 0,001) и отмечались более низкие значения тропонина (р = 0,001). Пациенты с ИМ2Т чаще имели анамнез ранее перенесенного ИМ (р &lt; 0,001) и реваскуляризации миокарда (р = 0,002]). Фракция выброса левого желудочка была сравнимой (р = 0.071), при этом большинство пациентов в обеих группах имели трехсосудистое поражение коронарных артерий при ангиографии (р &gt; 0,05). Независимыми предикторами ИМ2Т были наличие анемии (р &lt; 0,001), блокада левой ножки пучка Гиса (р = 0,019), отсутствие подъема сегмента ST на ЭКГ (р = 0,001), возраст ≥ 70 лет (р = 0,014) и нарушений локального сократимости при эхокардиографии (р = 0,002). Заключение: Инфаркт миокарда 2-го типа выявляется у значительной части пациентов с ИМ и независимо ассоциирован с пожилым возрастом, сопутствующей анемией, блокадой левой ножки пучка Гиса, отсутствием подъема ST на ЭКГ, нормальной сократимостью левого желудочка по данным эхокардиографии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>type 1 myocardial infarction</kwd><kwd>type 2 myocardial infarction</kwd><kwd>atherosclerosis</kwd><kwd>coronary angiography</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инфаркт миокарда первого типа</kwd><kwd>инфаркт миокарда второго типа</kwd><kwd>атеросклероз</kwd><kwd>коронарная ангиография</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Thygesen K. et al. Third universal definition of myocardial infarction. Circulation. 2012. Vol. 126. № 16. P. 2020—2035.</mixed-citation><mixed-citation xml:lang="ru">Thygesen K. et al. Third universal definition of myocardial infarction // Circulation. 2012. Vol. 126. № 16. P. 2020-2035.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Baron T. et al. Type 2 myocardial infarction in clinical practice. Heart. 2015. Vol. 101. № 2. P. 101—106.</mixed-citation><mixed-citation xml:lang="ru">Baron T. et al. Type 2 myocardial infarction in clinical practice // Heart. 2015. Vol. 101. № 2. P. 101-106.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Saaby L. et al. Mortality rate in type 2 myocardial infarction: Observations from an unselected hospital cohort. Am. J. Med. Elsevier Inc, 2014. Vol. 127. № 4. P. 295—302.</mixed-citation><mixed-citation xml:lang="ru">Saaby L. et al. Mortality rate in type 2 myocardial infarction: Observations from an unselected hospital cohort // Am. J. Med. Elsevier Inc, 2014. Vol. 127. № 4. P. 295-302.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Sandoval Y. et al. Supply/Demand Type 2 Myocardial Infarction. J. Am. Coll. Cardiol. 2014. Vol. 63. № 20. P. 2079—2087.</mixed-citation><mixed-citation xml:lang="ru">Sandoval Y. et al. Supply/Demand Type 2 Myocardial Infarction // J. Am. Coll. Cardiol. 2014. Vol. 63. № 20. P. 2079-2087.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Stein G.Y. et al. Type-II myocardial infarction — Patient characteristics, management and outcomes. PLoS One. 2014. Vol. 9. № 1. P. 1—6.</mixed-citation><mixed-citation xml:lang="ru">Stein G.Y. et al. Type-II myocardial infarction - Patient characteristics, management and outcomes // PLoS One. 2014. Vol. 9. № 1. P. 1-6.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Kuznetsova O.Yu. et al. The classification of acute myocardial infarction types and the preconditions for its development. Type II myocardial infarction. Russian family doctor. 2017. Vol. 21. No. 3. P. 5—15. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Кузнецова О.Ю. и др. Классификация типов острого инфаркта миокарда и предпосылки для ее создания. Инфаркт миокарда второго типа // Российский семейный врач. 2017. Т. 21. № 3. P. 5-15.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Saaby L. et al. Classification of myocardial infarction: Frequency and features of type 2 myocardial infarction. Am. J. Med. Elsevier Inc, 2013. Vol. 126. № 9. P. 789—797.</mixed-citation><mixed-citation xml:lang="ru">Saaby L. et al. Classification of myocardial infarction: Frequency and features of type 2 myocardial infarction // Am. J. Med. Elsevier Inc, 2013. Vol. 126, № 9. P. 789-797.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Sarkisian L. et al. Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated Troponins. Am. J. Med. Elsevier Inc, 2016. Vol. 129. № 4. P. 446.e5—446.e21.</mixed-citation><mixed-citation xml:lang="ru">Sarkisian L. et al. Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated Troponins // Am. J. Med. Elsevier Inc, 2016. Vol. 129. № 4. P. 446.e5-446.e21.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Cediel G. et al. Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury. Heart. 2017. Vol. 103. № 8. P. 616—622.</mixed-citation><mixed-citation xml:lang="ru">Cediel G. et al. Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury // Heart. 2017. Vol. 103. № 8. P. 616-622.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">López-Cuenca A. et al. Comparison between type-2 and type-1 myocardial infarction: Clinical features, treatment strategies and outcomes. J. Geriatr. Cardiol. 2016. Vol. 13. № 1. P. 15—22.</mixed-citation><mixed-citation xml:lang="ru">López-Cuenca A. et al. Comparison between type-2 and type-1 myocardial infarction: Clinical features, treatment strategies and outcomes // J. Geriatr. Cardiol. 2016. Vol. 13. № 1. P. 15-22.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Stein G.Y. et al. Type-II myocardial infarction-patient characteristics, management and outcomes. PLoS One. 2014. Vol. 9. № 1. P. e84285.</mixed-citation><mixed-citation xml:lang="ru">Stein G.Y. et al. Type-II myocardial infarction-patient characteristics, management and outcomes // PLoS One. 2014. Vol. 9. № 1. P. e84285.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Javed U. et al. Frequency of Elevated Troponin I and Diagnosis of Acute Myocardial Infarction. Am. J. Cardiol. Elsevier Inc., 2009. Vol. 104. № 1. P. 9—13.</mixed-citation><mixed-citation xml:lang="ru">Javed U. et al. Frequency of Elevated Troponin I and Diagnosis of Acute Myocardial Infarction // Am. J. Cardiol. Elsevier Inc., 2009. Vol. 104. № 1. P. 9-13.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Januzzi J.L. et al. The Many Faces of Type 2 Myocardial Infarction. J. Am. Coll. Cardiol. 2017. Vol. 70. № 13. P. 1569—1572.</mixed-citation><mixed-citation xml:lang="ru">Januzzi J.L. et al. The Many Faces of Type 2 Myocardial Infarction // J. Am. Coll. Cardiol. 2017. Vol. 70. № 13. P. 1569-1572.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Zharsky S. L. Type 2 myocardial infarction: Solved and unsolved issues. Heart: journal for practitioners. 2016. Vol. 92. No. (6). P. 404—409. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Жарский С.Л. Инфаркт миокарда второго типа: решенные и нерешенные вопросы // Сердце: журнал для практикующих врачей. 2016. Vol. 92. № (6). P. 404-409.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">McCarthy C.P. et al. Type 2 Myocardial Infarction — An Evolving Entity. Circ. J. 2018.</mixed-citation><mixed-citation xml:lang="ru">McCarthy C.P. et al. Type 2 Myocardial Infarction - An Evolving Entity // Circ. J. 2018.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Alpert J.S. et al. Diagnostic and Therapeutic Implications of Type 2 Myocardial Infarction: Review and Commentary. Am. J. Med. Elsevier Inc, 2014. Vol. 127. № 2. P. 105—108.</mixed-citation><mixed-citation xml:lang="ru">Alpert J.S. et al. Diagnostic and Therapeutic Implications of Type 2 Myocardial Infarction: Review and Commentary // Am. J. Med. Elsevier Inc, 2014. Vol. 127. № 2. P. 105-108.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Smilowitz N.R. et al. Diagnosis and Management of Type II Myocardial Infarction: Increased Demand for a Limited Supply of Evidence. Curr. Atheroscler. Rep. 2015. Vol. 17. № 2. P. 1—7.</mixed-citation><mixed-citation xml:lang="ru">Smilowitz N.R. et al. Diagnosis and Management of Type II Myocardial Infarction: Increased Demand for a Limited Supply of Evidence // Curr. Atheroscler. Rep. 2015. Vol. 17. № 2. P. 1-7.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Anderson J.L. et al. Acute Myocardial Infarction. N. Engl. J. Med. 2017. Vol. 376. № 21. P. 2053—2064.</mixed-citation><mixed-citation xml:lang="ru">Anderson J.L. et al. Acute Myocardial Infarction // N. Engl. J. Med. 2017. Vol. 376. № 21. P. 2053-2064.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Tweet M.S. et al. Unique Presentations and Etiologies of Myocardial Infarction in Women. Curr. Treat. Options Cardiovasc. Med. Current Treatment Options in Cardiovascular Medicine, 2017. Vol. 19. № 9.</mixed-citation><mixed-citation xml:lang="ru">Tweet M.S. et al. Unique Presentations and Etiologies of Myocardial Infarction in Women // Curr. Treat. Options Cardiovasc. Med. Current Treatment Options in Cardiovascular Medicine. 2017. Vol. 19. № 9.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Hanson I. et al. Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction. Catheter. Cardiovasc. Interv. 2013. Vol. 82. № 4. P. 622—628.</mixed-citation><mixed-citation xml:lang="ru">Hanson I. et al. Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction // Catheter. Cardiovasc. Interv. 2013. Vol. 82. № 4. P. 622-628.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Baron T. et al. Impact on Long-Term Mortality of Presence of Obstructive Coronary Artery Disease and Classification of Myocardial Infarction. Am. J. Med. 2016. Vol. 129. № 4. P. 398—406.</mixed-citation><mixed-citation xml:lang="ru">Baron T. et al. Impact on Long-Term Mortality of Presence of Obstructive Coronary Artery Disease and Classification of Myocardial Infarction // Am. J. Med. 2016. Vol. 129. № 4. P. 398-406.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Matsue Y. et al. Clinical Features and Prognosis of Type 2 Myocardial Infarction in Vasospastic Angina. Am. J. Med. Elsevier Inc, 2015. Vol. 128. № 4. P. 389—395.</mixed-citation><mixed-citation xml:lang="ru">Matsue Y. et al. Clinical Features and Prognosis of Type 2 Myocardial Infarction in Vasospastic Angina // Am. J. Med. Elsevier Inc, 2015. Vol. 128. № 4. P. 389-395.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Smilowitz N.R. et al. Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis. Int. J. Cardiol. Elsevier B.V., 2016. Vol. 218. P. 196—201.</mixed-citation><mixed-citation xml:lang="ru">Smilowitz N.R. et al. Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis // Int. J. Cardiol. Elsevier B.V., 2016. Vol. 218. P. 196-201.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Chapman A.R. et al. Refining the Diagnosis of Type 2 Myocardial Infarction. JAMA Cardiol. 2017. Vol. 2. № 1. P. 106.</mixed-citation><mixed-citation xml:lang="ru">Chapman A.R. et al. Refining the Diagnosis of Type 2 Myocardial Infarction // JAMA Cardiol. 2017. Vol. 2. № 1. P. 106.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Nestelberger T. et al. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction. J. Am. Coll. Cardiol. 2017. Vol. 70. № 13. P. 1558—1568.</mixed-citation><mixed-citation xml:lang="ru">Nestelberger T. et al. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction // J. Am. Coll. Cardiol. 2017. Vol. 70. № 13. P. 1558-1568.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
